8-K Announcements
6May 7, 2026·SEC
Apr 21, 2026·SEC
Feb 25, 2026·SEC
Aspen Aerogels, Inc. (ASPN) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's fundamental instability is highlighted by a -62.5% net margin and a volatile revenue trajectory that has seen a 51.9% decline in the most recent quarter.
Aspen Aerogels, Inc. (ASPN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Aspen Aerogels, Inc. (ASPN) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.28vs $0.27-3.7% | $38Mvs $37M+3.6% |
| Q1 2026 | Feb 25, 2026 | $0.34vs $0.27-25.9% | $41Mvs $44M-6.7% |
| Q4 2025 | Nov 6, 2025 | $0.06vs $0.21+72.1% | $73Mvs $44M+64.4% |
| Q3 2025 | Aug 7, 2025 | $0.04vs $0.12+66.7% | $78Mvs $70M+10.7% |
Key metrics vs top competitors for Aspen Aerogels, Inc. (ASPN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $5.14 | $425.99M | -1.08 | -40.11% | -143.69% | -91.64% | — | |
| $170.83 | $2.77B | 25.23 | 11.54% | 4.14% | 18.68% | — | |
| $85.44 | $4.85B | 17.09 | -4.99% | 4.27% | 8.41% | — | |
| $247.20 | $5.14B | 69.05 | 6.05% | 3.99% | 8.17% | — | |
| $142.22 | $11.45B | -22.72 | -7.95% | -5.42% | -12.38% | — | |
| $155.36 | $6.63B | 21.94 | 12.11% | 18.59% | 34.81% | — |
Aspen Aerogels, Inc. (ASPN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Aspen Aerogels, Inc. (ASPN) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 7, 2026·SEC
Apr 21, 2026·SEC
Feb 25, 2026·SEC
Get notified when ASPN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Aspen Aerogels, Inc. (ASPN) stock FAQ — growth, dividends, profitability & financials explained
Aspen Aerogels, Inc. (ASPN) reported $230.3M in revenue for fiscal year 2025. This represents a 705% increase from $28.6M in 2009.
Aspen Aerogels, Inc. (ASPN) saw revenue decline by 40.1% over the past year.
Aspen Aerogels, Inc. (ASPN) reported a net loss of $112.0M for fiscal year 2025.
Aspen Aerogels, Inc. (ASPN) has a return on equity (ROE) of -91.6%. Negative ROE indicates the company is unprofitable.
Aspen Aerogels, Inc. (ASPN) generated $35.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.